Libé R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E; ENSAT network (2015) Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann Oncol 26:2119-2125. https://doi.org/10.1093/annonc/mdv329

Article  PubMed  Google Scholar 

Armignacco R, Cantini G, Canu L, Poli G, Ercolino T, Mannelli M, Luconi M (2018) Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. J Endocrinol Invest 41:499-507. https://doi.org/10.1007/s40618-017-0775-y

Article  CAS  PubMed  Google Scholar 

Assié G, Jouinot A, Fassnacht M, Libé R, Garinet S, Jacob L, Hamzaoui N, Neou M, Sakat J, de La Villéon B, Perlemoine K, Ragazzon B, Sibony M, Tissier F, Gaujoux S, Dousset B, Sbiera S, Ronchi CL, Kroiss M, Korpershoek E, de Krijger R, Waldmann J, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Luconi M, Mannelli M, Groussin L, Bertagna X, Baudin E, Amar L, Coste J, Beuschlein F, Bertherat J (2019) Value of molecular classification for prognostic assessment of adrenocortical carcinoma. JAMA Oncol 5:1440-1447. https://doi.org/10.1001/jamaoncol.2019.1558

Article  PubMed  Google Scholar 

Clay MR, Pinto EM, Fishbein L, Else T, Kiseljak-Vassiliades K (2022) Pathological and genetic stratification for management of adrenocortical carcinoma. J Clin Endocrinol Metab 107:1159-1169. https://doi.org/10.1210/clinem/dgab866

Article  PubMed  Google Scholar 

Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, Papotti MG (2022) Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol 33:155-196. https://doi.org/10.1007/s12022-022-09710-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lalli E, Luconi M (2018) The next step: mechanisms driving adrenocortical carcinoma metastasis. Endocr Relat Cancer 25:R31-R48. https://doi.org/10.1530/ERC-17-0440

Article  CAS  PubMed  Google Scholar 

Cantini G, Canu L, Armignacco R, Salvianti F, De Filpo G, Ercolino T, Nesi G, Maggi M, Mannelli M, Pinzani P, Luconi M (2020) Prognostic and monitoring value of circulating tumor cells in adrenocortical carcinoma: a preliminary monocentric study. Cancers (Basel) 12:3176. https://doi.org/10.3390/cancers12113176

Article  CAS  PubMed  Google Scholar 

WHO Classification of Tumours Editorial Board (2022) WHO classification of endocrine and neuroendocrine tumours. IARC, France, Lyon

Pennanen M, Heiskanen I, Sane T, Remes S, Mustonen H, Haglund C, Arola J (2015) Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas. Hum Pathol 46:404-410. https://doi.org/10.1016/j.humpath.2014.11.015

Article  PubMed  Google Scholar 

Duregon E, Fassina A, Volante M, Nesi G, Santi R, Gatti G, Cappellesso R, Dalino Ciaramella P, Ventura L, Gambacorta M, Dei Tos AP, Loli P, Mannelli M, Mantero F, Berruti A, Terzolo M, Papotti M (2013) The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases. Am J Surg Pathol 37:1433-1440. https://doi.org/10.1097/PAS.0b013e31828d387b

Article  PubMed  Google Scholar 

Jolliffe IT (2002) Principal Component Analysis. Springer Series in Statistics. Springer, New York. https://doi.org/10.1007/0-387-22440-8_13

Lau SK, Weiss LM (2009) The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40:757-768. https://doi.org/10.1016/j.humpath.2009.03.010

Article  PubMed  Google Scholar 

Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B; German Adrenocortical Carcinoma Registry Group; European Network for the Study of Adrenal Tumors (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115:243-250. https://doi.org/10.1002/cncr.24030

Article  Google Scholar 

Duregon E, Cappellesso R, Maffeis V, Zaggia B, Ventura L, Berruti A, Terzolo M, Fassina A, Volante M, Papotti M (2017) Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma. Hum Pathol 62:1-7. https://doi.org/10.1016/j.humpath.2016.09.035

Article  PubMed  Google Scholar 

Baechle JJ, Marincola Smith P, Solórzano CC, Tran TB, Postlewait LM, Maithel SK, Prescott J, Pawlik T, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin L, Abbott DE, Ronnekleiv-Kelly S, Sicklick JK, Yopp A, Mansour J, Duh QY, Seiser N, Votanopoulos K, Levine EA, Poultsides G, Kiernan CM (2021) Cumulative GRAS score as a predictor of survival after resection for adrenocortical carcinoma: analysis from the U.S. adrenocortical carcinoma database. Ann Surg Oncol 28:6551-6561. https://doi.org/10.1245/s10434-020-09562-8

Article  PubMed  Google Scholar 

Giordano TJ, Berney D, de Krijger RR, Erickson L, Fassnacht M, Mete O, Papathomas T, Papotti M, Sasano H, Thompson LDR, Volante M, Gill AJ (2021) Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Hum Pathol 110:50-61. https://doi.org/10.1016/j.humpath.2020.10.001

Article  PubMed  Google Scholar 

Coste J, Tissier F, Pouchot J, Ecosse E, Rouquette A, Bertagna X, Libé R, Viallon V (2014) Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer. Cancer Epidemiol 38:200-208. https://doi.org/10.1016/j.canep.2014.02.004

Article  PubMed  Google Scholar 

Warde KM, Lim YJ, Ribes Martinez E, Beuschlein F, O'Shea P, Hantel C, Dennedy MC (2022) Mitotane targets lipid droplets to induce lipolysis in adrenocortical carcinoma. Endocrinology 163: bqac102. https://doi.org/10.1210/endocr/bqac102

Lacombe AMF, Soares IC, Mariani BMP, Nishi MY, Bezerra-Neto JE, Charchar HDS, Brondani VB, Tanno F, Srougi V, Chambo JL, Costa de Freitas RM, Mendonca BB, Hoff AO, Almeida MQ, Weigand I, Kroiss M, Zerbini MCN, Fragoso MCBV (2020) Sterol O-acyl transferase 1 as a prognostic marker of adrenocortical carcinoma. Cancers (Basel) 12:247. https://doi.org/10.3390/cancers12010247.5

Article  CAS  PubMed  Google Scholar 

Armignacco R, Cantini G, Poli G, Guasti D, Nesi G, Romagnoli P, Mannelli M, Luconi M (2019) The adipose stem cell as a novel metabolic actor in adrenocortical carcinoma progression: evidence from an in vitro tumor microenvironment crosstalk model. Cancers (Basel) 11:1931. https://doi.org/10.3390/cancers11121931

Article  CAS  PubMed  Google Scholar 

Cantini G, Di Franco A, Mannelli M, Scimè A, Maggi M, Luconi M (2020) The role of metabolic changes in shaping the fate of cancer-associated adipose stem cells. Front Cell Dev Biol 8:332. https://doi.org/10.3389/fcell.2020.00332

Article  PubMed  PubMed Central  Google Scholar 

Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, Libé R, Ardito A, Al Ghuzlan A, Quinkler M, Oßwald A, Ronchi CL, de Krijger R, Feelders RA, Waldmann J, Willenberg HS, Deutschbein T, Stell A, Reincke M, Papotti M, Baudin E, Tissier F, Haak HR, Loli P, Terzolo M, Allolio B, Müller HH, Fassnacht M (2015) Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab 100:841-849. https://doi.org/10.1210/jc.2014-3182

Article  CAS  PubMed  Google Scholar